Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Mol Neurobiol ; 60(10): 6121-6132, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37421564

ABSTRACT

Neuropathic pain affects globally about 7-10% of the general population. Electroacupuncture (EA) effectively relieves neuropathic pain symptoms without causing any side effects; however, the underlying molecular mechanisms remain unclear. We established a chronic constriction injury (CCI)-induced rat model of neuropathic pain. RNA sequencing was used to screen for differentially expressed genes in the dorsal root ganglion after CCI and EA treatment. We identified gene markers of ferroptosis spermidine/spermine N1-acetyltransferase 1 (Sat1) and arachidonate 15-lipoxygenase (Alox15) to be dysregulated in the CCI-induced neuropathic pain model. Furthermore, EA relieved CCI-induced pain as well as ferroptosis-related symptoms in the dorsal root ganglion, including lipid peroxidation and iron overload. Finally, SAT1 knockdown also alleviated mechanical and thermal pain hypersensitivity and reversed ferroptosis damage. In conclusion, we showed that EA inhibited ferroptosis by regulating the SAT1/ALOX15 pathway to treat neuropathic pain. Our findings provide insight into the mechanisms of EA and suggest a novel therapeutic target for neuropathic pain.


Subject(s)
Electroacupuncture , Ferroptosis , Neuralgia , Rats , Humans , Animals , Rats, Sprague-Dawley , Ganglia, Spinal/metabolism , Arachidonate 15-Lipoxygenase/metabolism , Neuralgia/therapy , Neuralgia/metabolism
2.
J Biomol Struct Dyn ; 41(24): 15219-15233, 2023.
Article in English | MEDLINE | ID: mdl-36914235

ABSTRACT

Bruton tyrosine kinase (BTK) is a known drug target for the treatment of autoimmune diseases, including rheumatoid arthritis (RA). In this study, a series of 1-amino-1H-imidazole-5-carboxamide derivatives with good inhibitory activity against BTK were selected to explore the structure-activity relationships of these BTK inhibitors (BTKIs). Furthermore, we concentrated on 182 prescriptions of Traditional Chinese Medicine with therapeutic effects on RA. 54 herbs with a frequency of ≥10 were counted to establish a database containing 4027 ingredients for virtual screening. Five compounds with relatively higher docking scores and better absorption, distribution, metabolism, elimination and toxicity (ADMET) parameters were then selected for higher precision docking. The results demonstrated that the potentially active molecules form hydrogen bond interactions with the hinge region residues Met477, Glu475, glycine-rich P-loop residue Val416, Lys430 and DFG motif Asp539. In particular, they also interact with the key residues Thr474 and Cys481 of BTK. The molecular dynamics (MD) results demonstrated that all five compounds above could bind with BTK stably as its cognate ligand in dynamic conditions. This work identified several potential BTKIs using a computer-aided drug design approach and may provide crucial information for developing novel BTKIs.Communicated by Ramaswamy H. Sarma.


Subject(s)
Arthritis, Rheumatoid , Protein-Tyrosine Kinases , Humans , Agammaglobulinaemia Tyrosine Kinase , Medicine, Chinese Traditional , Molecular Docking Simulation , Quantitative Structure-Activity Relationship , Protein Kinase Inhibitors/chemistry , Molecular Dynamics Simulation , Structure-Activity Relationship , Arthritis, Rheumatoid/drug therapy
3.
Biol Trace Elem Res ; 198(1): 1-7, 2020 Nov.
Article in English | MEDLINE | ID: mdl-31950399

ABSTRACT

The purpose of this study was to investigate the effect of iodine supplementation during pregnancy on thyroid function and also its effect on postpartum depression in an iodine-sufficient area. Healthy pregnant women were divided into three groups: group A (vitamin iodine-150) receiving vitamin containing 150 µg iodine, group B (vitamin iodine-0) receiving vitamin without iodine, and group C (no vitamin) receiving no vitamin. General information was collected by questionnaire and thyroid function was determined in the third trimester of pregnancy. Depression was assessed 1 month postpartum by the Edinburgh postnatal depression scale (EPDS). The results showed that there was no significant difference in thyroid-stimulating hormone (TSH) level among the three groups (P > 0.05). FT4 concentration was significantly lower in group A (n = 234: 10.68 pmol/L) than in group B (n = 220: 11.47 pmol/L) and group C (n = 195: 11.64 pmol/L) (P < 0.05), However, it was still within the normal range. EPDS scores obtained from group B (3.50) and group C (3.00) were similar but markedly lower than group A (5.00) (P < 0.05). Despite the difference in the EPDS score, the prevalence of postpartum depression was not significantly different among the three groups. In conclusion, 150 µg/day iodine supplementation for pregnant women in areas with adequate iodine had little effect on thyroid function in the third trimester, and serum FT4 level could not be increased. Iodine supplementation during pregnancy also had no significant effect on postpartum depression.


Subject(s)
Depression, Postpartum , Iodine , Depression, Postpartum/drug therapy , Depression, Postpartum/epidemiology , Depression, Postpartum/prevention & control , Dietary Supplements , Female , Humans , Pregnancy , Thyroid Function Tests , Thyroid Gland , Thyrotropin , Thyroxine , Vitamins
4.
Pediatr Dermatol ; 37(1): 222-223, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31626359

ABSTRACT

Staphylococcal scalded skin syndrome causes widespread skin denudation primarily in infants < 1 year old. Selection of empiric therapy is complicated by rising rates of antibiotic resistance in community-acquired staphylococcal infections. Consistent with a previous study, this retrospective review found that SSSS-associated isolates were more likely to be clindamycin-resistant and less likely to be methicillin-resistant compared to overall staphylococcal infections. We favor cephalosporins and penicillinase-resistant penicillins (eg, oxacillin) for empiric management of SSSS, with consideration of adding MRSA coverage in communities with high MRSA prevalence or failure to improve following several days of treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Staphylococcal Scalded Skin Syndrome/drug therapy , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , Drug Resistance, Bacterial , Female , Humans , Infant , Infant, Newborn , Male , Methicillin Resistance , Microbial Sensitivity Tests , Penicillin Resistance , Retrospective Studies , Sensitivity and Specificity , Staphylococcal Scalded Skin Syndrome/microbiology , Staphylococcus aureus/isolation & purification
5.
Bioorg Med Chem Lett ; 30(3): 126885, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31862411

ABSTRACT

In order to explore novel Aurora kinase inhibitors, a series of novel 2,4-disubstituted pyrimidines were designed, synthesized and evaluated their in vitro anti-proliferative activities against a panel of cancerous cell lines (A549, HCT-116 and MCF-7). Among them, compound 12a showed the moderate to high anti-proliferative activities against A549 (IC50 = 12.05 ± 0.45 µM), HCT-116 (IC50 = 1.31 ± 0.41 µM) and MCF-7 (IC50 = 20.53 ± 6.13 µM) cells, as well as the Aurora A and Aurora B inhibitory activities with the IC50 values of 309 nM and 293 nM, respectively. Furthermore, compound 12a induced apoptosis by upregulated the pro-apoptotic proteins Bax and decreased the anti-apoptotic protein Bcl-xl in HCT-116 cells. Moreover, the molecular docking study showed that compound 12a had good binding modes with Aurora A and Aurora B and the bioinformatics prediction discovered that compound 12a exhibited good drug likeness using SwissADME. Taken together, these results indicated that 12a may be a potential anticancer compound that was worthy of further development as Aurora kinase inhibitor.


Subject(s)
Aurora Kinase A/antagonists & inhibitors , Aurora Kinase B/antagonists & inhibitors , Protein Kinase Inhibitors/chemistry , Pyrimidines/chemistry , Apoptosis/drug effects , Aurora Kinase A/metabolism , Aurora Kinase B/metabolism , Binding Sites , Cell Line, Tumor , Drug Design , Drug Evaluation, Preclinical , Drug Screening Assays, Antitumor , Humans , Molecular Docking Simulation , Protein Kinase Inhibitors/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Structure, Tertiary , Pyrimidines/metabolism , Pyrimidines/pharmacology , Structure-Activity Relationship , bcl-2-Associated X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL